How Not to Miss Autoinflammatory Diseases Masquerading As Urticaria
Total Page：16
File Type：pdf, Size：1020Kb
Allergy REVIEW ARTICLE How not to miss autoinflammatory diseases masquerading as urticaria K. Krause1,2, C. E. Grattan3, C. Bindslev-Jensen4, M. Gattorno5, T. Kallinich1,6, H. D. de Koning7,8, H. J. Lachmann9, D. Lipsker10, A. A. Navarini11, A. Simon7, C. Traidl-Hoffmann12,13 & M. Maurer1,2 1Autoinflammation Reference Center Charite´ , Charite´ -Universita¨tsmedizin Berlin, Berlin, Germany; 2Department of Dermatology and Allergy, Charite´-Universita¨tsmedizin Berlin, Berlin, Germany; 3St John’s Institute of Dermatology, St Thomas’ Hospital, London, UK; 4Department of Dermatology and Allergy Center, Odense University Hospital, Odense, Denmark; 5UO Pediatria II, G. Gaslini Institute, Genova, Italy; 6Pediatric Pneumology and Immunology, Charite´ -Universita¨tsmedizin Berlin, Berlin, Germany; 7Department of General Internal Medicine, Nijmegen Institute for Infection, Inflammation and Immunology (N4i), Centre for Immunodeficiency and Autoinflammation (NCIA), Radboud University Nijmegen Medical Centre; 8Department of Dermatology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; 9National Amyloidosis Centre, University College London Medical School, London, UK; 10Faculte´ de Me´ decine, Hoˆ pitaux universitaires de Strasbourg, Universite´ de Strasbourg et Clinique Dermatologique, Strasbourg, France; 11Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; 12Department of Dermatology and Allergy Biederstein, Technische Universita¨t, Munich, Germany; 13ZAUM – Center for Allergy and Environment, Technische Universita¨t Munich, Helmholtz Center Munich, Munich, Germany To cite this article: Krause K, Grattan CE, Bindslev-Jensen C, Gattorno M, Kallinich T, de Koning HD, Lachmann HJ, Lipsker D, Navarini AA, Simon A, Traidl-Hoffmann C, Maurer M. How not to miss autoinflammatory diseases masquerading as urticaria. Allergy 2012; 67: 1465–1474. Keywords Abstract autoinflammation; cryopyrin-associated Urticarial skin reactions are one of the most frequent problems seen by allergists periodic syndrome; interleukin-1; Schnitzler’s syndrome; urticaria. and clinical immunologists in daily practice. The most common reason for recur- rent wheals is spontaneous urticaria. There are, however, several less common Correspondence diseases that present with urticarial rash, such as urticarial vasculitis and autoin- Marcus Maurer, Department of Dermatology flammatory disorders. The latter include cryopyrin-associated periodic syndrome and Allergy, Charite´ – Universita¨tsmedizin and Schnitzler’s syndrome, both rare and disabling conditions mediated by Berlin, Charite´ platz 1, D-10117 Berlin, increased interleukin-1 secretion. Apart from the urticarial rash, patients are suf- Germany. fering from a variety of systemic symptoms including recurrent fever attacks, Tel.: +49 30 450 518 043 arthralgia or arthritis and fatigue. Autoinflammatory diseases are often associated Fax: +49 30 450 518 972 with a diagnostic delay of many years and do not respond to antihistamines and E-mail: [email protected] other treatments of urticaria. Also, the chronic inflammation may lead to long- Accepted for publication 15 August 2012 term complications such as amyloidosis. It is therefore important not to miss these diseases when diagnosing and treating patients with chronic recurrent urti- DOI:10.1111/all.12030 carial rash. Here, we present clinical clues and tips that can help to identify autoinflammatory disorders in patients presenting with chronic urticarial rash Edited by: Hans-Uwe Simon and discuss their clinical picture and management. Abbreviations Urticarial rash: a diagnostic conundrum AOSD, Adult-onset Still’s disease; CAPS, Cryopyrin-associated Urticarial rashes are among the most frequent problems seen periodic syndrome; CRP, C-reactive protein; CSU, Chronic by allergists and clinical immunologists in daily practice. spontaneous urticaria; ESR, Erythrocyte sedimentation rate; FCAS, Patients present with multiple wheal-and-flare-type skin Familial cold autoinflammatory syndrome; FMF, Familial lesions that are usually itchy. Acute urticaria is characterized Mediterranean fever; HIDS, Hyper-IgD and periodic fever syndrome; MAS, Macrophage activation syndrome; MKD, by transient recurrent wheals and/or angioedema for up to Mevalonate kinase deficiency; MWS, Muckle–Wells syndrome; 6 weeks. It may be associated with acute upper respiratory NOMID, Neonatal onset multisystem inflammatory disease; tract viral infections or intolerance reactions to foods or PFAPA, Periodic fever, aphthous stomatitis, pharyngitis and drugs (1). In most cases, symptoms rapidly cease to occur adenitis; SAA, Serum amyloid A; SchS, Schnitzler’s syndrome; after a couple of days or weeks, and the causes of acute urti- SLE, Systemic lupus erythematosus; soJIA, Systemic-onset caria are usually not a reason for ongoing concern. juvenile idiopathic arthritis; TNF, Tumour necrosis factor; TRAPS, Chronic urticaria is much less common than acute urticaria TNF-receptor-associated periodic syndrome. but still a frequent condition. In patients with recurrent Allergy 67 (2012) 1465–1474 © 2012 John Wiley & Sons A/S 1465 Chronic urticarial rash: signs for autoinflammation Krause et al. wheals, chronic spontaneous urticaria (CSU) is the most complications, impaired quality of life and long-term, often common underlying disease (Table 1). Chronic spontaneous poorly effective, immunosuppressive therapies including sys- urticaria, that is, recurrent spontaneous wheals, angioedema temic glucocorticoids and others which carry their own seri- or both occurring on a regular basis for more than 6 weeks, ous side effects. Despite some recent important advances, the has a point prevalence of 0.5–1% in the European popula- diagnosis and treatment of autoinflammatory syndromes tion (2). It is often associated with intolerance reactions to remain challenging. Skin manifestations such as urticarial food and drugs, chronic infections and autoreactivity (i.e. rash are among the earliest and most prominent symptoms in inflammatory skin reactions after intracutaneous injection of these disorders. In fact, urticarial eruptions are prototypic autologous serum) or functional autoantibodies (1). In addi- skin lesions of autoinflammatory conditions and can help to tion, there are a number of inducible forms of chronic urti- identify these diseases in their early stages (Table 2). caria (e.g. dermographic, cold-induced, solar, cholinergic urticaria), which are elicited by physical or other stimuli such Cryopyrin-associated periodic syndrome as water, UV light or an increase in body temperature. The underlying mechanisms of inducible chronic urticarias are Urticarial rash, or in some cases maculo-papular rash, occurs largely unknown. As in spontaneous urticaria, the first-line in almost all patients with CAPS. Further symptoms include symptomatic treatment of choice is the use of nonsedating recurrent fever attacks, arthralgia or arthritis, eye inflamma- antihistamines (3). Importantly there are several much less tion, fatigue and headaches. Cryopyrin-associated periodic common diseases all of them autoinflammatory disorders, syndrome, also called cryopyrinopathies, used to be classified that mimick urticaria (4) (Table 1). as three distinct entities and was previously referred to as familial cold autoinflammatory syndrome (FCAS), Muckle– Wells syndrome (MWS) or neonatal onset multisystem Autoinflammatory diseases inflammatory disease (NOMID). It is now clear that CAPS In contrast to autoimmune diseases, which are mediated by covers a continuum of disease severity with considerable T and B cells and other key players of adaptive immunity, overlap in clinical symptoms and a lack of clear genotype/ autoinflammatory diseases are disorders of the innate phenotype correlation (8) (Table 2). With about 1000 known immune system. The best understood autoinflammatory dis- patients worldwide, CAPS represents an orphan disease. It is eases are the hereditary periodic fever syndromes, which caused by autosomal dominant mutations in the NLRP3 include cryopyrin-associated periodic syndrome (CAPS), gene that encodes cryopyrin, a key component of an intracel- familial Mediterranean fever (FMF), hyper-IgD syndrome lular multiprotein complex, named the NLRP3 inflamma- (HIDS) and TNF-receptor-associated periodic syndrome some, which regulates the processing of interleukin-1b (TRAPS). They are characterized by episodic fever and (IL-1b), a potent pro-inflammatory cytokine (9). The sponta- chronic inflammation of the skin, joints and various other neous secretion of IL-1b from macrophages (10) and skin organs. Amyloid A amyloidosis as a result of the chronic mast cells of patients with CAPS (11) as well as the dramatic inflammation is the most serious long-term complication of response to treatment with IL-1b neutralizing drugs (12–14) these diseases (5). Patients often suffer from a markedly indicates that IL-1b plays a central role in the pathogenesis impaired quality of life, and the number of missed school of CAPS. Cryopyrin-associated periodic syndrome is diag- and working days is high (6, 7). nosed on the basis of the clinical presentation, family history Autoinflammatory disorders are very rare entities, and and laboratory work-up including mutation analysis. The limited disease awareness even among specialist physicians treatment with IL-1b neutralizing drugs has been shown to often results in a diagnostic delay of many years or even dec- be effective and well-tolerated in all three subgroups of ades. Delay in diagnosis